Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death

By Filigheddu Nicoletta   Fubini Alberto   Baldanzi Gianluca   Cutrupi Santina   Ghè Corrado   Catapano Filomena   Broglio Fabio   Bosia Amalia   Papotti Mauro   Muccioli Giampiero   Ghigo Ezio   Deghenghi Romano   Graziani Andrea  

Endocrine Journal, Vol. 14, Iss. 1, 2001-02 ,pp. : 113-119

Humana Press, Inc

Access to resources Recommend Favorite

Imaging of early modification in cardiomyopathy: the doxorubicin-induced model

By Aissiou Mohamed   Périé Delphine   Cheriet Farida   Dahdah Nagib   Laverdière Caroline   Curnier Daniel  

The International Journal of Cardiovascular Imaging, Vol. 29, Iss. 7, 2013-10 ,pp. : 1459-1476

Springer Publishing Company

Access to resources Recommend Favorite

Contractile Failure in Chronic Doxorubicin-induced Cardiomyopathy

By Boucek Jr R.J.   Dodd D.A.   Atkinson J.B.   Oquist N.   Olson R.D.  

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 10, 1997-10 ,pp. : 2631-2640

Academic Press

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor on Delayed-Onset Doxorubicin-Induced Cardiotoxicity

By Boucek Robert J.   Steele Ann   Miracle Ann   Atkinson James  

Cardiovascular Toxicology, Vol. 3, Iss. 4, 2003-12 ,pp. : 319-330

Humana Press, Inc

Access to resources Recommend Favorite

Activation of A₃Adenosine Receptor Protects Against Doxorubicin-induced Cardiotoxicity

By Shneyvays V.   Mamedova L.   Zinman T.   Jacobson K.   Shainberg A.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 6, 2001-06 ,pp. : 1249-1261

Academic Press

Access to resources Recommend Favorite